Browsing by Subject "monosialoganglioside"
Now showing items 1-5 of 5
-
Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice
(Springer, 1999-01-01)Some experimental evidence suggests that the beneficial effects of monosialoganglioside GM1 on learning and memory could be related to an improving effect in central cholinergic function. the present study investigates the ...
-
GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid
(Elsevier B.V., 2003-04-01)The effects of the administration of monosialoganglioside (GM1) on methylmalonic acid (MMA)-induced convulsions, production of thiobarbituric acid reactive substances (TBARS) and on the striatal content of ascorbic acid ...
-
Monosialoganglioside (GM(1)) attenuates the behavioural effects of longterm haloperidol administration in supersensitive rats
(Elsevier B.V., 2004-03-01)In the present study we investigated the effects of co-administration of GM(1) (15.0 mg/kg, twice daily, for 30 days) and haloperidol (1.0 mg/kg, twice daily, for 30 days), as well as the effects of a 5-day treatment with ...
-
Monosialoganglioside attenuates the excitatory and behavioural sensitization effects of ethanol
(Elsevier B.V., 1996-10-17)The effects of long-term monosialoganglioside G(M1) treatment on the acute excitatory effects of ethanol and behavioural sensitization to this effect were studied, using locomotion frequency of mice observed in an open ...
-
Repeated monosialoganglioside administration attenuates behavioral sensitization to amphetamine
(Elsevier B.V., 1997-01-30)The effects of repeated monosialoganglioside (GM1) administration on amphetamine-induced behavioral sensitization were studied using locomotion frequency of mice observed in an open-field as an experimental parameter. GM1 ...
